Notably, the suppression of CRC cell proliferation, invasion, and migration achieved through miR-661 downregulation was reversed upon the silencing of TUSC2, suggesting that miR-661 exerts oncogenic effects, potentially by targeting TUSC2. The gene discussed is TUSC2; the disease is colorectal carcinoma.